(0.79%) 5 104.44 points
(0.86%) 38 556 points
(1.53%) 16 083 points
(-0.47%) $78.58
(3.00%) $2.10
(-0.32%) $2 302.10
(-0.94%) $26.58
(0.02%) $962.75
(-0.39%) $0.929
(-1.25%) $10.85
(-0.14%) $0.797
(0.36%) $91.45
-1.30% $ 0.289
Live Chart Being Loaded With Signals
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 49 565.00 |
Średni wolumen | 239 122 |
Kapitalizacja rynkowa | 3.28M |
EPS | $0 ( 2024-03-27 ) |
Następna data zysków | ( $-0.870 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0500 |
ATR14 | $0.00500 (1.73%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-19 | Murphy James B | Buy | 0 | |
2024-01-02 | Fortress Biotech, Inc. | Buy | 419 092 | COMMON STOCK, PAR VALUE $0.0001 |
2023-12-11 | Carney Peter | Sell | 0 | Common Stock |
2023-07-05 | Zelefsky Michael J | Buy | 7 246 | COMMON STOCK, PAR VALUE $0.0001 |
2023-07-05 | Chill Adam J. | Buy | 7 246 | COMMON STOCK, PAR VALUE $0.0001 |
INSIDER POWER |
---|
100.00 |
Last 97 transactions |
Buy: 5 442 388 | Sell: 2 083 593 |
Wolumen Korelacja
Mustang Bio Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
JRJC | 0.953 |
HAIN | 0.949 |
LUCD | 0.949 |
APVO | 0.936 |
POAI | 0.934 |
NOVN | 0.933 |
SHEN | 0.932 |
AUBN | 0.929 |
EZGO | 0.928 |
MPAA | 0.927 |
10 Najbardziej negatywne korelacje | |
---|---|
SMTC | -0.956 |
SCTL | -0.956 |
PPTA | -0.956 |
NKTR | -0.95 |
STAA | -0.945 |
MOTNU | -0.94 |
IGLD | -0.936 |
VRME | -0.935 |
IVCB | -0.934 |
VITL | -0.934 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Mustang Bio Inc Korelacja - Waluta/Towar
Mustang Bio Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.23M (0.00 %) |
EPS: | $-6.00 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.23M (0.00 %) |
EPS: | $-6.00 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-3.03M (0.00 %) |
EPS: | $-11.44 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.760 |
Financial Reports:
No articles found.
Mustang Bio Inc
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm, acute myeloid leukemia, and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clin Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH, and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej